Leaders at Jefferson Health spoke with The Morning Call about changes in leadership, progress on integrating the two networks ...
A clinical team has spearheaded the use of CAR-T cell therapy for blood cancers. The researchers recently treated the first ...
In just over a year since its US Food and Drug Administration (FDA) approval, pirtobrutinib (Jayprica) has become a standard ...
In an early-stage clinical trial, the therapy nearly doubled the expected survival time of young patients. Still, experts ...
Azercabtagene zapreleucel has been granted fast track designation from the FDA for the treatment of diffuse large B-cell ...
Data incorporated for this study were collected from 9 centers in the UK focused on third-line and beyond chimeric antigen ...
Driving Restrictions Beyond 1 Month After CAR-T Therapy Not Needed for All Patients, Researchers Say
Researchers proposed changing the recommendations for universal driving restrictions after CAR T-cell infusion.
The FDA cleared the investigational new drug (IND) application for EVM14. EVM14 is an off-the-shelf tumor-associated antigen ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback